Showing results (271-280 of 405) with videos related to
Sort By:
Pageof 41
British Journal of Clinical Pharmacology|February 18, 2014
Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associationsYuan Ji, Daniel J Schaid, Zeruesenay Desta, et al.Journal of the American Heart Association|November 3, 2025
Admixture Mapping of Lipid Traits in Hispanic AmericansKeyue Ding, Angad S Johar, Arslan Zaidi, et al.Human Genetics|December 11, 2007
Fine mapping of familial prostate cancer families narrows the interval for a susceptibility locus on chromosome 22q12.3 to 1.36 MbBo Johanneson, Shannon K McDonnell, Danielle M Karyadi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2011
Genetic variation predicting cisplatin cytotoxicity associated with overall survival in lung cancer patients receiving platinum-based chemotherapyXiang-Lin Tan, Ann M Moyer, Brooke L Fridley, et al.European Journal of Nuclear Medicine and Molecular Imaging|March 1, 2014
Impact of right-ventricular apical pacing on the optimal left-ventricular lead positions measured by phase analysis of SPECT myocardial perfusion imagingGuang-Uei Hung, Jin-Long Huang, Wan-Yu Lin, et al.Medicine|February 18, 2016
LV Dyssynchrony Is Helpful in Predicting Ventricular Arrhythmia in Ischemic Cardiomyopathy After Cardiac Resynchronization Therapy: A Preliminary StudyShih-Chuan Tsai, Yu-Cheng Chang, Kuo-Feng Chiang, et al.BMC Medical Genomics|September 17, 2021
An association study in the Taiwan Biobank elicits the GABAA receptor genes GABRB3, GABRA5, and GABRG3 as candidate loci for sleep duration in the Taiwanese populationSheue-Jane Hou, Shih-Jen Tsai, Po-Hsiu Kuo, et al.Pharmacogenetics and Genomics|December 17, 2011
Gemcitabine metabolic pathway genetic polymorphisms and response in patients with non-small cell lung cancerLiang Li, Daniel J Schaid, Brooke L Fridley, et al.Breast Cancer Research and Treatment|January 11, 2015
A polygenic risk score for breast cancer in women receiving tamoxifen or raloxifene on NSABP P-1 and P-2Celine M Vachon, Daniel J Schaid, James N Ingle, et al.Oncotarget|November 22, 2017
Network-directed cis-mediator analysis of normal prostate tissue expression profiles reveals downstream regulatory associations of prostate cancer susceptibility lociNicholas B Larson, Shannon K McDonnell, Zach Fogarty, et al.Pageof 41